Cercar
16/02/2024
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
Carrick, RT, De Marco, C, Gasperetti, A, Bosman, LP, Gourraud, JB, Trancuccio, A, Mazzanti, A, Murray, B, Pendleton, C, Tichnell, C, Tandri, H, Zeppenfeld, K, Wilde, AAM, Davies, B, Seifer, C, Roberts, JD, Healey, JS, MacIntyre, C, Alqarawi, W, Tadros, R, Cutler, MJ, Targetti, M, Calò, L, Vitali, F, Bertini, M, Compagnucci, P, Casella, M, Dello Russo, A, Cappelletto, C, De Luca, A, Stolfo, D, Duru, F, Jensen, HK, Svensson, A, Dahlberg, P, Hasselberg, NE, Di Marco, A, Jordà, P, Arbelo, E, Weidmann, ZM, Borowiec, K, Delinière, A, Biernacka, EK, van Tintelen, JP, Platonov, PG, Olivotto, I, Saguner, AM, Haugaa, KH, Cox, M, Tondo, C, Merlo, M, Krahn, AD, te Riele, ASJM, Wu, KC, Calkins, H, James, CA, Cadrin-Tourigny, J. Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe. EUROPEAN HEART JOURNAL. 2024; 45(7)DOI:10.1093/eurheartj/ehad799. PMID:38195003. IF:35.600(Q1/1D).
16/02/2024
National expert consensus on home-administered oncologic therapies in Spain
Villegas, E, Arruñada, M, Casado, MA, González, S, Moreno-Martínez, ME, Peñuelas, MA, Torres, AM, Sierra, Y, Seguí, MA. National expert consensus on home-administered oncologic therapies in Spain. Frontiers in Oncology. 2024; 14DOI:10.3389/fonc.2024.1335344. PMID:38434688. IF:3.300(Q2/4D).
15/02/2024
Thirty-year of genetic counselling education in Europe: a growing professional area
Paneque, M, O'Shea, R, Narravula, A, Siglen, E, Ciuca, A, Abuli, A, Serra-Juhé, C. Thirty-year of genetic counselling education in Europe: a growing professional area. EUROPEAN JOURNAL OF HUMAN GENETICS. 2024; DOI:10.1038/s41431-024-01552-8. PMID:38355960. IF:4.600(Q1/2D).
15/02/2024
Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies.
Genua I, Cusi K. Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies.. Diabetes Spectrum : A Publication Of The American Diabetes Association. 2024; 37(1)DOI:10.2337/dsi23-0012. PMID:38385098. IF:(Q/D).
14/02/2024
The influence of gender in cognitive insight and cognitive bias in people with first-episode psychosis: an uncontrolled exploratory analysis
Espinosa, V, Naides, N, López-Carrilero, R, Vila-Badia, R, Colomer-Salvans, A, Barajas, A, Barrigón, ML, Birulés, I, Butjosa, A, Díaz-Cutraro, L, Del Cacho, N, Frigola-Capell, E, González-Higueras, F, Grasa, E, Gutiérrez-Zotes, A, Lorente-Rovira, E, Moreno-Kustner, B, Pélaez, T, Pousa, E, Ruiz-Delgado, I, Serra-Arumí, C, Verdaguer-Rodríguez, M, Grp Profep Spanish Metacognition Grp, Usall, J, Ochoa, S. The influence of gender in cognitive insight and cognitive bias in people with first-episode psychosis: an uncontrolled exploratory analysis. Archives of Womens Mental Health. 2024; 27(5)DOI:10.1007/s00737-024-01425-5. PMID:38353751. IF:2.700(Q2/4D).
14/02/2024
HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial
Bais, T, Meijer, E, Kramers, BJ, Vart, P, Vervloet, M, Salih, M, Bammens, B, Demoulin, N, Todorova, P, Müller, RU, Halbritter, J, Paliege, A, Gall, ECL, Knebelmann, B, Torra, R, Ong, ACM, Frankl, FEK, Gansevoort, RT. HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial. Trials. 2024; 25(1)DOI:10.1186/s13063-024-07952-x. PMID:38355627. IF:2.000(Q3/7D).